Physician

Camille G. Frazier-Mills, M.D.

According to 2025 Medicare claims, Camille Frazier-Mills, M.D. (NPI: 1346383593) practices cardiac electrophysiology in the Durham-Chapel Hill, NC market, with the plurality of this provider's patient population coming from Durham, NC. This provider's primary affiliated billing organization is DUKE HEALTH INTEGRATED PRACTICE, INC. (NPI: 1205553369; TIN: 862109896) and primary practice location at 27560-5676. Frazier-Mills is affiliated with the Duke Connected Care, LLC (ACO ID: A2419), participating under the MSSP model.

Frazier-Mills' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,339 traditional Medicare patients, billed 3,532 HCPCS/CPT codes, and received $132,771 in Medicare payments. The top billing code was 93298 (Evaluation of cardiac rhythm monitor system, remote up to 30 days). Part D data shows 698 prescription claims across 146 beneficiaries totaling $220,414 in drug costs, led by Eliquis (Apixaban). Open Payments data shows 157 records totaling $155,948. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have fallen sharply in recent years, from $145,960 to $220,414. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,109	1,865	$106,621
2016	1,093	1,855	$114,270
2017	886	1,420	$95,332
2018	2,319	3,100	$97,353
2019	3,865	5,190	$112,397
2020	1,950	2,717	$83,913
2021	1,164	2,905	$104,364
2022	979	2,338	$83,227
2023	1,267	3,199	$102,061
2024	1,339	3,532	$132,771

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	146	1,026	$145,960
2016	143	1,064	$144,275
2017	151	882	$343,843
2018	119	594	$554,828
2019	109	546	$354,707
2020	100	505	$305,165
2021	110	519	$181,752
2022	108	504	$172,578
2023	112	489	$154,415
2024	146	698	$220,414

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93298	Evaluation of cardiac rhythm monitor system, remote up to 30 days	150	282	$72
93295	Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days	381	502	$25
93294	Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days	588	781	$20
93296	Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days	984	1,306	$14
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	69	96	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	165	8,150	$155,270
Xarelto	Rivaroxaban	25	1,110	$19,513
Multaq	Dronedarone Hcl	23	750	$18,856
Amiodarone Hcl	Amiodarone Hcl	66	4,086	$1,830
Midodrine Hcl	Midodrine Hcl	27	1,350	$1,782

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	133	$37,570	Medtronic, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	24	$118,378	Medtronic, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Camille G. Frazier-Mills, M.D.?

Tedicare shows public-source Medicare data for Camille G. Frazier-Mills, M.D. (NPI 1346383593), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Camille G. Frazier-Mills, M.D. have ACO affiliation data?

Camille G. Frazier-Mills, M.D. is shown with ACO affiliation data for Duke Connected Care, LLC (MSSP, ACO ID A2419).

What billing organization is linked to Camille G. Frazier-Mills, M.D.?

Camille G. Frazier-Mills, M.D. is linked to DUKE HEALTH INTEGRATED PRACTICE, INC. (billing NPI 1205553369) in the available physician profile data.

Does Camille G. Frazier-Mills, M.D. have Open Payments data?

Camille G. Frazier-Mills, M.D. has 157 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.